• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝性脑病管理中的重要未决问题:ISHEN 共识。

Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.

机构信息

Virginia Commonwealth University, McGuire VA Medical Center, Richmond, Virginia, USA.

Hospital of South West Jutland, Esbjerg, Denmark.

出版信息

Am J Gastroenterol. 2020 Jul;115(7):989-1002. doi: 10.14309/ajg.0000000000000603.

DOI:10.14309/ajg.0000000000000603
PMID:32618647
Abstract

Management of hepatic encephalopathy (HE) remains challenging from a medical and psychosocial perspective. Members of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism recognized 5 key unresolved questions in HE management focused on (i) driving, (ii) ammonia levels in clinical practice, (iii) testing strategies for covert or minimal HE, (iv) therapeutic options, and (v) nutrition and patient-reported outcomes. The consensus document addresses these topical issues with a succinct review of the literature and statements that critically evaluate the current science and practice, laying the groundwork for future investigations.

摘要

从医学和社会心理角度来看,肝性脑病(HE)的管理仍然具有挑战性。国际肝脏性脑病和氮代谢学会的成员确定了 5 个HE 管理方面未解决的关键问题,重点关注(i)驾驶,(ii)临床实践中的氨水平,(iii)隐匿性或轻微 HE 的检测策略,(iv)治疗选择,以及(v)营养和患者报告的结局。这份共识文件通过简洁地回顾文献和批判性评估当前科学和实践,解决了这些热门问题,为未来的研究奠定了基础。

相似文献

1
Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.肝性脑病管理中的重要未决问题:ISHEN 共识。
Am J Gastroenterol. 2020 Jul;115(7):989-1002. doi: 10.14309/ajg.0000000000000603.
2
Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy.轻微肝性脑病和显性肝性脑病的临床及神经学表现
Clin Liver Dis. 2015 Aug;19(3):461-72. doi: 10.1016/j.cld.2015.05.003.
3
Management of overt hepatic encephalopathy.显性肝性脑病的治疗。
Clin Liver Dis. 2012 Feb;16(1):73-89. doi: 10.1016/j.cld.2011.12.007.
4
Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy.隐匿性/轻微肝性脑病诊断与治疗的最新进展
Expert Rev Gastroenterol Hepatol. 2016;10(4):443-50. doi: 10.1586/17474124.2016.1141675. Epub 2016 Mar 11.
5
Chinese guidelines on management of hepatic encephalopathy in cirrhosis.《肝硬化肝性脑病诊治指南》
World J Gastroenterol. 2019 Sep 28;25(36):5403-5422. doi: 10.3748/wjg.v25.i36.5403.
6
Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.综述文章:肝性脑病临床试验设计——国际肝性脑病和氮代谢学会(ISHEN)共识声明。
Aliment Pharmacol Ther. 2011 Apr;33(7):739-47. doi: 10.1111/j.1365-2036.2011.04590.x. Epub 2011 Feb 9.
7
Management of covert hepatic encephalopathy.隐匿性肝性脑病的管理。
Clin Liver Dis. 2012 Feb;16(1):91-3. doi: 10.1016/j.cld.2011.12.006. Epub 2012 Jan 13.
8
Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.暴发性肝衰竭中肝性脑病的诊断与管理
Clin Liver Dis. 2015 Aug;19(3):565-76. doi: 10.1016/j.cld.2015.04.006. Epub 2015 May 26.
9
Hepatic encephalopathy.肝性脑病。
Clin Liver Dis. 2012 May;16(2):301-20. doi: 10.1016/j.cld.2012.03.009.
10
Nutritional support in hepatic encephalopathy.肝性脑病的营养支持
Nutrition. 1999 Mar;15(3):220-8. doi: 10.1016/s0899-9007(98)00191-9.

引用本文的文献

1
Simple scoring model for predicting overt hepatic encephalopathy in geriatric cirrhosis: A multicenter retrospective cohort study.预测老年肝硬化患者显性肝性脑病的简易评分模型:一项多中心回顾性队列研究。
Metab Brain Dis. 2025 Sep 10;40(7):263. doi: 10.1007/s11011-025-01691-x.
2
Hepatic encephalopathy in cirrhosis: therapies and developments.肝硬化中的肝性脑病:治疗方法与进展
Metab Brain Dis. 2025 May 7;40(5):198. doi: 10.1007/s11011-025-01598-7.
3
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.
日本隐匿性肝性脑病的当前管理与未来展望:一项全国性调查
J Gastroenterol. 2025 Mar 7. doi: 10.1007/s00535-025-02232-0.
4
LIVE-SMART: A sequential, multiple assignment randomized trial to reduce falls in cirrhosis.LIVE-SMART:一项旨在减少肝硬化患者跌倒的序贯、多组分配随机试验。
Hepatol Commun. 2025 Feb 19;9(3). doi: 10.1097/HC9.0000000000000626. eCollection 2025 Mar 1.
5
Relationship between Sarcopenia and minimal hepatic encephalopathy in patients with cirrhosis: a prospective observational study.肝硬化患者肌肉减少症与轻微肝性脑病之间的关系:一项前瞻性观察研究。
BMC Gastroenterol. 2025 Feb 17;25(1):88. doi: 10.1186/s12876-025-03674-9.
6
Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis.评估血浆神经退行性生物标志物在诊断中国肝硬化患者轻微肝性脑病及预测显性肝性脑病中的作用
J Clin Transl Hepatol. 2025 Jan 28;13(1):35-46. doi: 10.14218/JCTH.2024.00413. Epub 2024 Dec 12.
7
Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide.肝硬化急性失代偿住院后的门诊管理:实用指南。
World J Hepatol. 2024 Dec 27;16(12):1377-1394. doi: 10.4254/wjh.v16.i12.1377.
8
External validation of EncephalApp Stroop test to screen minimal hepatic encephalopathy patients with nonalcoholic cirrhosis.用于筛查非酒精性肝硬化所致轻微肝性脑病患者的EncephalApp斯特鲁普测试的外部验证
World J Hepatol. 2024 Dec 27;16(12):1450-1457. doi: 10.4254/wjh.v16.i12.1450.
9
Ammonia-induced stress response in liver disease progression and hepatic encephalopathy.氨诱导的肝疾病进展和肝性脑病的应激反应。
Nat Rev Gastroenterol Hepatol. 2024 Nov;21(11):774-791. doi: 10.1038/s41575-024-00970-9. Epub 2024 Sep 9.
10
Gut microbiome profiles to exclude the diagnosis of hepatic encephalopathy in patients with cirrhosis.肠道微生物组谱排除肝硬化患者肝性脑病的诊断。
Gut Microbes. 2024 Jan-Dec;16(1):2392880. doi: 10.1080/19490976.2024.2392880. Epub 2024 Aug 27.